HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 160 filers reported holding HERON THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 2.49 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $36 | 0.0% | 31,185 | 0.0% | 0.02% | 0.0% |
| Q2 2023 | $36 | -83.9% | 31,185 | -78.9% | 0.02% | -81.8% |
| Q1 2023 | $223 | -39.7% | 147,862 | 0.0% | 0.13% | -37.4% |
| Q4 2022 | $370 | -99.8% | 147,862 | +179.7% | 0.21% | +48.6% |
| Q3 2022 | $223,000 | +51.7% | 52,862 | 0.0% | 0.14% | +61.4% |
| Q2 2022 | $147,000 | -51.8% | 52,862 | -0.9% | 0.09% | -44.7% |
| Q1 2022 | $305,000 | -37.4% | 53,362 | 0.0% | 0.16% | -35.1% |
| Q4 2021 | $487,000 | -14.4% | 53,362 | +0.2% | 0.24% | -16.7% |
| Q3 2021 | $569,000 | -36.0% | 53,262 | -7.0% | 0.29% | -30.3% |
| Q2 2021 | $889,000 | +247.3% | 57,261 | +262.4% | 0.42% | +257.6% |
| Q1 2021 | $256,000 | +6.2% | 15,799 | +38.6% | 0.12% | -9.2% |
| Q4 2020 | $241,000 | +62.8% | 11,400 | +14.0% | 0.13% | +21.5% |
| Q3 2020 | $148,000 | +0.7% | 10,000 | 0.0% | 0.11% | +2.9% |
| Q2 2020 | $147,000 | +25.6% | 10,000 | 0.0% | 0.10% | -11.1% |
| Q1 2020 | $117,000 | – | 10,000 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG KEVIN C | 760 | $783 | 100.00% |
| Velan Capital Investment Management LP | 6,986,744 | $7,196,346 | 5.80% |
| Tejara Capital Ltd | 2,109,681 | $2,172,971 | 1.23% |
| JW Asset Management, LLC | 2,407,418 | $2,479,641 | 1.07% |
| Rubric Capital Management LP | 26,713,503 | $27,514,908 | 1.03% |
| GREAT POINT PARTNERS LLC | 4,737,368 | $4,879,489 | 0.89% |
| Orchard Capital Management, LLC | 2,142,823 | $2,207,108 | 0.82% |
| Clearline Capital LP | 6,149,842 | $6,334,338 | 0.54% |
| CM Management, LLC | 450,000 | $463,500 | 0.49% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 327,450 | $337,274 | 0.48% |